Compare AU

Compare CURE vs. QPON

Compare shares and ETFs on the ASX that you can trade on Pearler.

Global X S&P Biotech ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the BetaShares Australian Bank Senior Floating Rate Bond ETF (QPON). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

CURE

QPON

Popularity

Low

Low

Pearlers invested

80

10

Median incremental investment

$620.00

$4,650.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,296.12

$3,651.20

Average age group

> 35

> 35


Key Summary

CURE

QPON

Strategy

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

QPON.AX was created on 2017-06-01 by BetaShares. The fund's investment portfolio concentrates primarily on high yield fixed income. The ETF currently has 1617.95m in AUM and 13 holdings. QPON.AX aims to track the performance of an index (before fees and expenses) that measures the performance of a portfolio of some of the largest and most liquid senior floating rate bonds issued by Australian banks.

Top 3 holdings

AbbVie Inc (2.62 %)

Alnylam Pharmaceuticals Inc (2.59 %)

Amgen Inc (2.59 %)

COMMONWEALTH BANK OF AUSTRALIA FRN AUG-29 (10.75 %)

NATIONAL AUSTRALIA BANK LTD FRN NOV-29 (10.25 %)

WESTPAC BANKING CORP FRN SEP-29 (9.79 %)

Top 3 industries

Health Care (100.00 %)

Other (10.24 %)

Other (96.47 %)

Communication Services (3.53 %)

Top 3 countries

United States (97.17 %)

Switzerland (1.51 %)

United Kingdom of Great Britain and Northern Ireland (1.16 %)

Management fee

0.45 %

0.22 %


Key Summary

CURE

QPON

Issuer

Global X

BetaShares

Tracking index

S&P Biotechnology Select Industry

Solactive Australian Bank Senior Floating Rate Bond Index - AUD

Asset class

ETF

ETF

Management fee

0.45 %

0.22 %

Price

$48.91

$26.08

Size

$36.111 million

$1.620 billion

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.24 %

2.69 %

Market

ASX

ASX

First listed date

12/11/2018

06/06/2017

Purchase fee

$6.50

$6.50


Community Stats

CURE

QPON

Popularity

Low

Low

Pearlers invested

80

10

Median incremental investment

$620.00

$4,650.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,296.12

$3,651.20

Average age group

> 35

> 35


Pros and Cons

CURE

QPON

Pros

  • Higher exposure to US market

  • Higher distribution yield

  • Lower management fee

  • Higher price growth

Cons

  • Higher management fee

  • Lower price growth

  • Lower exposure to US market

  • Lower distribution yield

CURE

QPON

Higher exposure to US market

Lower exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield

Home